Data suggest that taletrectinib “provides clinically meaningful tumor shrinkage and prolonged disease control as a treatment option for advanced ROS1+ NSCLC, regardless of treatment history,” ...

The DOJ has sent letters to CHEST and other journals asking that editors answer questions about bias and misinformation.

The combination of toripalimab, nimotuzumab, and chemotherapy showed “promising antitumor activity with acceptable toxicity,” researchers wrote.

This move is the latest in a series of attempts by the Trump administration to eliminate DEI/DEIA programs and reduce NIH funding.

CAR T-cell therapy showed encouraging efficacy and good safety in newly diagnosed Ph-positive ALL,” the researchers wrote.

Progress has been made in reducing overall cancer mortality, largely driven by sustained declines in lung cancer,” the researchers wrote.

Atezolizumab may improve upon perioperative treatment with trastuzumab and chemotherapy in HER2+, locally advanced, resectable gastric or GEJ cancer, researchers say.

Firings at the HHS included the entire office that sets federal poverty guidelines, which determine whether Americans are eligible for programs such as Medicaid.

Source: Getty Images “When leveraged to their appropriate context and strengths, under the care of an oncologist, cancer-related apps can actually strengthen the bond with the physician and care ...

Pediatric cancer patients and their caregivers largely prefer to access test results immediately through the patient portal rather than wait to hear about results from oncologists, according to survey ...

Until prospective data are available, researchers recommend that patients with ER-low breast cancer “should be counseled regarding the potential benefit” of adjuvant endocrine therapy.